Advertisement

Selected Disorders of the Musculoskeletal System

  • Sangita Chakrabarty
  • Nia Foderingham
  • Heather O’Hara
Living reference work entry

Abstract

Fibromyalgia is a common syndrome characterized by generalized pain present for greater than 3 months, joint stiffness, fatigue, mood disorders, cognitive dysfunction, nonrestorative sleep, and tender points.

Keywords

Trigger Point Complex Regional Pain Syndrome Giant Cell Tumor Tender Point Ganglion Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Smythe HA, Moldofsky H. Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis. 1977–1978;28(1):928–31.Google Scholar
  2. 2.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.CrossRefPubMedGoogle Scholar
  4. 4.
    Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10(8):777–91.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Staud R, Smitherman M. Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep. 2002;6(4):259–66.CrossRefPubMedGoogle Scholar
  6. 6.
    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.CrossRefGoogle Scholar
  7. 7.
    Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Busch AJ, Barber KAR, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;(4):CD003786.Google Scholar
  9. 9.
    Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796.Google Scholar
  10. 10.
    Simons DG. Muscular pain syndromes. In: JR Fricton, EA Award (Eds.), Myofascial pain and fibromyalgia, Advances in pain research and therapy (2nd ed.), Raven Press, New York, vol. 17. 1990. p. 1–41.Google Scholar
  11. 11.
    Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2011;25(2):185–98.CrossRefPubMedGoogle Scholar
  12. 12.
    Simons DG, Travell JG, Simons LS. Travell and Simons’ myofascial pain and dysfunction: the trigger point manual. vol 1. Upper half of body. 2nd ed. Baltimore: Williams & Wilkins; 1999.Google Scholar
  13. 13.
    Maihöfner C, Seifert F, Markovic K. Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol. 2010;17(5):649–60.CrossRefPubMedGoogle Scholar
  14. 14.
    Cossins L, Okell RW, Cameron H, Simpson B, Poole HM, Goebel A. Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain. 2013;17(2):158–73.CrossRefPubMedGoogle Scholar
  15. 15.
    Badalamente MA, Hurst LC, Ellstein J, McDevitt CA. The pathobiology of human neuromas: an electron microscopic and biochemical study. J Hand Surg Br. 1985;10(1):49–53.CrossRefPubMedGoogle Scholar
  16. 16.
    Brogan DM, Kakar S. Management of neuromas of the upper extremity. Hand Clin. 2013;29(3):409–20.CrossRefPubMedGoogle Scholar
  17. 17.
    Worrell M. Dupuytren’s disease. Orthopedics. 2012;35(1):52–60.CrossRefPubMedGoogle Scholar
  18. 18.
    Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011;36(5):936–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Darowish M, Sharma J. Evaluation and treatment of chronic hand conditions. Med Clin North Am. 2014;98(4):801–15.CrossRefPubMedGoogle Scholar
  20. 20.
    Garcia RA, Inwards CY, Unni KK. Benign bone tumors-recent developments. Semin Diagn Pathol. 2011;28:73–85.CrossRefPubMedGoogle Scholar
  21. 21.
    Sinelnikov A, Kale H. Osteochondromas of the spine. Clin Radiol. 2014;69:e584–90.CrossRefPubMedGoogle Scholar
  22. 22.
    Motamedi K, Seeger LL. Benign bone tumors. Radiol Clin North Am. 2011;49:1115–34.CrossRefPubMedGoogle Scholar
  23. 23.
    Qasem SA, DeYoung BR. Cartilage-forming tumors. Semin Diagn Pathol. 2014;31(1):10–20.CrossRefPubMedGoogle Scholar
  24. 24.
    Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM. Giant cell tumor of bone. Orthopedics. 2014;37(2):112–20.CrossRefPubMedGoogle Scholar
  25. 25.
    Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ. What’s new in primary malignant musculoskeletal tumors. J Bone Joint Surg Am. 2013;95(24):2240–6.CrossRefPubMedGoogle Scholar
  26. 26.
    HaDuong JH, Martin AA, Skapek SX, Mascarenhas L. Sarcomas. Pediatr Clin North Am. 2015;62(1):179–200.CrossRefPubMedGoogle Scholar
  27. 27.
    Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ. What’s new in primary bone tumors. J Bone Joint Surg Am. 2012;94(20):1913–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Donaldson SS. Ewing sarcoma: radiation dose and target volume. Pediatr Blood Cancer. 2004;42(5):471–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115(7):1531–43.PubMedCentralCrossRefPubMedGoogle Scholar
  31. 31.
    Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, et al. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys. 2012;84(1):224–30.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Shimose S, Kubo T, Fujimori J, Furuta T, Ochi M. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents. J Orthop Sci. 2014;19(6):997–1003. doi:10.1007/s00776-014-0617-0.CrossRefPubMedGoogle Scholar
  33. 33.
    Chen J, Sun MX, Hua YQ, Cai ZD. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(7):1205–10.CrossRefPubMedGoogle Scholar
  34. 34.
    Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013;95(13):e89.PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    van Maldegem AM, Bovée JV, Gelderblom H. Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013. Clin Sarcoma Res. 2014;4:11.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Ollivier L, Vanel D, Leclère J. Imaging of chondrosarcomas. Cancer Imaging. 2003;4(1):36–8.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Fuji H, Nakasu Y, Ishida Y, Horiguchi S, Mitsuya K, Kashiwagi H, et al. Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base. Skull Base. 2011;21(3):201–6.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, Zeuli M, Giannarelli D, Cognetti F, Biagini R. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010;10:22.PubMedCentralCrossRefPubMedGoogle Scholar
  39. 39.
    Coleman R. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.CrossRefPubMedGoogle Scholar
  40. 40.
    Ohmori K, Matsui H, Yasuda T, Kanamori M, Yudoh K, Seto H, Tsuji H. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams. Jpn J Clin Oncol. 1997;27(4):263–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew Jr JC, Stavropoulos MF. The non-ossifying fibroma: a case report and review of the literature. Head Neck Pathol. 2013;7(2):203–10.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Shaker JL. Paget’s disease of bone: a review of epidemiology, pathophysiology and management. Ther Adv Musculoskelet Dis. 2009;1(2):107–25.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Arnold LM, Clauw DJ, Dunegan LJ, Turk DC, FibroCollaborative. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc. 2012;87(5):488–96.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Sangita Chakrabarty
    • 1
  • Nia Foderingham
    • 1
    • 2
  • Heather O’Hara
    • 1
    • 2
  1. 1.Division of Occupational and Preventive Medicine, Department of Family and Community MedicineMeharry Medical CollegeNashvilleUSA
  2. 2.Department of Family and Community MedicineMeharry Medical CollegeNashvilleUSA

Personalised recommendations